Anti-Cytochrome P450 2C8 Antibody

This polyclonal antibody from Antibodies.com targets human cytochrome P450 2C8 (CYP2C8), a key hepatic enzyme in the CYP2C subfamily that metabolizes xenobiotics and clinically important drugs such as paclitaxel, amodiaquine, and repaglinide. Raised in rabbit and supplied as 100 µl of unconjugated antiserum, it is validated for western blot and immunohistochemistry workflows, supporting studies in drug metabolism, pharmacogenomics, and hepatic tissue characterization. Researchers investigating CYP2C8-mediated biotransformation, interindividual variability in drug clearance, or isoform-specific expression patterns in liver and extrahepatic tissues rely on polyclonal reagents to capture multiple epitopes across the target protein. The unconjugated format allows flexible pairing with secondary antibodies labeled with HRP, fluorophores, or biotin depending on the chosen detection chemistry.